Skip to main content
OpenTrials

Clinical trial condition

Erdheim-Chester Disease

Explore clinical trials studying Erdheim-Chester Disease. Study availability and eligibility vary by location and protocol.

7 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Erdheim-Chester Disease trial results

Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT05768178

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
View all 16 locations
View Trial Details
Recruiting

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

NCT04079179

Conditions
Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +18 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
View Trial Details
Not Yet Recruiting

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +77 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details

Related conditions